期刊文献+

缺氧微环境下缺氧诱导因子-1α对前列腺癌细胞上皮间质转化的影响 被引量:9

Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells
暂未订购
导出
摘要 目的探讨缺氧诱导因子-1α在缺氧的条件下对前列腺癌细胞发生上皮间质转化的影响。方法在缺氧的环境中培养前列腺癌细胞PC3,并应用分子生物学的方法检测其是否是发生上皮间质转化的关键转录因子。结果缺氧微环境可以诱导前列腺癌细胞PC3发生上皮间质转化,缺氧诱导因子-1α起关键的调节作用,并且可以增强前列腺癌细胞的侵袭能力。缺氧条件下抑制缺氧诱导因子-1α的表达可以阻止前列腺癌细胞发生上皮间质转化。结论缺氧微环境通过缺氧诱导因子-1α诱导前列腺癌细胞PC3发生上皮间质转化。 Objective To explore the influence of hypoxia-inducible factor-1α(HIF-1α) on prostate cancer epithelial to mesenchymal transition(EMT) under hypoxic conditions. Methods In this study we carried out several methods in molecular biology to test whether PC3, a human prostate cancer cell line, underwent typical epithelial to mesenchymal transition under hypoxia and the key regulator of this process. Results We demonstrated that hypoxia induced diverse molecular, phenotypic, and functional changes in prostate cancer cells that are consistent with EMT. We also showed that HIF-1α, which is thought to be stabilized under hypoxic environment, is involved in EMT and cancer cell invasive potency. Hypoxia-induced EMT in prostate cancer cells is blocked by HIF-1α gene silencing. Conclusion EMT may be induced in hypoxic prostate cancer cells, by a mechanism that involves activation of HIF-1α-dependent cell signaling.
出处 《首都医科大学学报》 CAS 2014年第3期278-283,共6页 Journal of Capital Medical University
基金 国家自然科学基金(81341066) 北京市卫生系统高层次卫生技术人才基金(2013-2-003) 北京安贞医院院长科技发展基金(2013Z03)~~
关键词 缺氧微环境 缺氧诱导因子-1Α 前列腺癌 上皮间质转化 hypoxic environment hypoxia-indueible factor-1α prostate cancer epithelial to mesenchymal transition
  • 相关文献

参考文献38

  • 1Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013 [J]. CA CancerJClin, 2013,63(1) :11-30.
  • 2Vaupel P, Kelleher D K, Hockel M. Oxygen status of ma- lignant tumors : pathogenesis of hypoxia and significance for tumor therapy [ J ]. Semin Oncol, 2001,28 ( 2 Suppl 8 ) :29- 35.
  • 3Evans S M, Koch C J. Prognostic significance of tumor oxy- genation in humans[J]. Cancer Lett, 2003,195 ( 1 ) : 1 - 16.
  • 4Parker C, Milosevic M, Toi A, et al. Polarographic elec- trode study of tumor oxygenation in clinically localized pros- tate cancer [ J]. Int J Radiat Oncol Biol Plays, 2004,58 (3) :750-757.
  • 5Cvetkovic D, Movsas B, Dicker A P, et al. Increased hy- poxia correlates with increased expression of the angiogene-sis marker vascular endothelial growth factor in human pros- tate cancer[J]. Urology, 2001,57(4) :821-825.
  • 6Movsas B, Chapman J D, Greenberg R E, et al. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: An Eppendorf po(2) study[J]. Cancer, 2000,89(9) :2018-2024.
  • 7Carnell D M, Smith R E, Daley F M, et al. An immuno- histochemical assessment of hypoxia in prostate carcinoma using pimonidazole : implications for radioresistance [ J ]. Int J Radiat Oncol Biol Phys, 2006,65(1) :91-99.
  • 8Vergis R, Corbishley C M, Norman A R, et al. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: A retro- spective analysis of two randomised radiotherapy trims and one surgical cohort study[ J ]. Lancet Oncol, 2008,9 (4) : 342-351.
  • 9Berx G, Raspe E, Christofori G, et al. Pre-EMTting metas- tasis? Recapitulation of morphogenetic processes in cancer [J]. Clin Exp Metastasis, 2007,24(8):587-597.
  • 10Morel A P, Lievre M, Thomas C, et al. Generation of breast cancer stem cells through epithelial-mesenchymal transition[J]. PLoS One, 2008,3(8) :e2888.

二级参考文献22

  • 1Semenza GL. HIFI: upstream and downstream of cancer me- tabolismp[J]. Curt Opin Genet Dev, 2010,20(1) : 51-56.
  • 2Mei YK,Taly RS,Garth P. HIF-la and cancer therapy[J]. Re- cent Results Cancer Res,2010,180(1) :15-34.
  • 3Tacchini L, Dnasi P, Matteucci E, et al. Hepatocyte growth factor signaling stimulates hypoxia inducible factor-la(HIF-la) activity in HepG2 hepatoma cells[J]. Carcinogenesis, 2001,22 (9) : 1363- 1371.
  • 4Tacchini L, Matteucci E, DePonti C, et al. Hepatocyte growth factor signaling regulates transactivation of genes belonging to the plasminogen activation system via hypoxia inducible factor l[J]. Exp Cell Res,2003,290(2):39-401.
  • 5Tacehini L, De Ponti C, Matteucci E, et al. Hepatocyte growth factor-activated NF-kappaB regulates HIF-lc ctivity and ODC expression,implicated in suvrival, dieffrently in dieffrent carcino- ma cell lines[J]. Canerinogenesis, 2004,25 ( 11 ) : 2089-2100.
  • 6Fabiola C,Daniel CR,Donald PB. Targeting the HGF/Met signa ling pathway in cancer[J]. Euro J Cancer, 2010, 46 (7): 1260- 1270.
  • 7Pennacchietti S, Michieli P, Galluzzo M, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protoon- cogene[J]. Cancer Cell, 2003,3 (4) : 347-361.
  • 8Takao I, Yoshihiko K, Atsushi M, et al. Tumor-stromal cell in- teraction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/C-Met path- way[J]. Int J Cancer,2006,119(12) :2750-2759.
  • 9Takao I, Yoshihiko K, Atsushi M, et al. The hypoxic environ- ment in tumor- stromal cells accelerates pancreatic cancer pro- gression via the activation of paracrine hepatocyte growth factor/ C-Met signaling[J]. Ann Surg Oncol, 2007,14 (9) : 2600-2607.
  • 10Hu YL,DeLay M,Jahanqiri A ,et al. Hypoxia-induced autophagypromotes tumor cell survival and adaptation to antiangiogenictreatment in glioblastoma [J], Cancer Res, 2012,72(7): 1773-1783.

共引文献16

同被引文献85

  • 1黄军,袁盾,刘定阳,李坚,李岩,Walter A Hall,李波.靶向uPAR的免疫毒素对人胶质母细胞瘤及其血管生成的影响(英文)[J].中南大学学报(医学版),2014,39(1). 被引量:4
  • 2韩冰,付小兵.间充质干细胞的研究进展与临床应用前景[J].中国修复重建外科杂志,2006,20(12):1257-1261. 被引量:22
  • 3黄智芬,黎汉忠,张作军,施智严.健脾化瘀汤配合化疗治疗晚期大肠癌34例临床观察[J].中国中医药科技,2006,13(6):431-432. 被引量:5
  • 4Hsieh YF, Liu GY, Lee YJ, et al. Transglutaminase 2 contributes to apoptosis induction inJ urkat T cells by modulating Ca2+ homeostasis via cross-linking RAP1GDS1[J]. PLoS One, 2013, 8(2), e81516.
  • 5Han AL, Kumar S, FokJY, et al. Tissue transglutaminase expression promotes castration-resistant phenotype and transcrip- tional repression of androgen receptor[J]. EurJ Cancer, 2014, 50(9), 1685-1696.
  • 6Vuoriluoto K, Haugen H, Kiviluoto S, et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer[J]. Oncogene, 2011,30(12),1436-1448.
  • 7Yoshida T, Ozawa Y, Kimura T, et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states[J]. BrJ Cancer, 2014, 110(6),1497-1505.
  • 8Oh K, Ko E, Kim HS, et al. Transglutaminase 2 facilitates the distant hematogenous metastasis of breast cancer by modulating interleukin-6 in cancer cells[J]. Breast Cancer Res,2011, 13(5), R96.
  • 9Watanabe H. Extracellular matrix-regulation of cancer invasion and metastasis[J]. Gan To Kagaku Ryoho , 2010, 37 (11), 2058-2061.
  • 10Devereux G, Steele S, Iagelman T, et al. An observational study of matrix metalloproteinase (MMP)-9 in cystic fibrosis[J].J Cyst Fibros, 2014,13(5) ,557-563.

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部